Swiss Pharmaceuticals & Biotech Potentially Undervalued Companies

Cosmo Pharmaceuticals

Market Cap: CHF 1.0b

Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.

Teva Pharmaceutical Industries

Market Cap: CHF 18.6b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Novartis

Market Cap: CHF 191.7b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Johnson & Johnson

Market Cap: CHF 432.8b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Bayer

Market Cap: CHF 19.3b

Operates as a life science company worldwide.

Bristol-Myers Squibb

Market Cap: CHF 100.3b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Joincare Pharmaceutical Group IndustryLtd

Market Cap: US$22.6b

Joincare Pharmaceutical Group Industry Co.,Ltd.

AstraZeneca

Market Cap: CHF 170.6b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Novartis

Market Cap: CHF 191.7b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Newron Pharmaceuticals

Market Cap: CHF 218.8m

A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

PolyPeptide Group

Market Cap: CHF 773.6m

Operates as a contract development and manufacturing company in Europe, the United States, and India.

Jazz Pharmaceuticals

Market Cap: CHF 7.0b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Merck KGaA

Market Cap: CHF 46.4b

Operates as a science and technology company in Germany.

BioMarin Pharmaceutical

Market Cap: CHF 10.3b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Tecan Group

Market Cap: CHF 1.8b

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.

Gilead Sciences

Market Cap: CHF 94.1b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Qiagen

Market Cap: CHF 9.2b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Gerresheimer

Market Cap: CHF 1.2b

Provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.

Roche Holding

Market Cap: CHF 219.7b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Roche Holding

Market Cap: CHF 219.7b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Evotec

Market Cap: CHF 1.9b

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

Biogen

Market Cap: CHF 27.0b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Siegfried Holding

Market Cap: CHF 3.4b

Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.

Eli Lilly

Market Cap: CHF 650.4b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

Merck

Market Cap: CHF 196.2b

Operates as a healthcare company worldwide.

CRISPR Therapeutics

Market Cap: CHF 5.6b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

SKAN Group

Market Cap: CHF 1.2b

Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.

Amgen

Market Cap: CHF 145.8b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Siegfried Holding

Market Cap: CHF 3.9b

Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.

Kuros Biosciences

Market Cap: CHF 932.9m

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

UCB

Market Cap: CHF 16.3b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

Basilea Pharmaceutica

Market Cap: CHF 567.1m

A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.

Santhera Pharmaceuticals Holding

Market Cap: CHF 136.9m

A specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.

CSL

Market Cap: CHF 101.7b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.